These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

747 related articles for article (PubMed ID: 12116690)

  • 1. Irritable bowel syndrome: update on pathogenesis and management.
    Alaradi O; Barkin JS
    Med Princ Pract; 2002; 11(1):2-17. PubMed ID: 12116690
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Irritable bowel syndrome: new agents targeting serotonin receptor subtypes.
    De Ponti F; Tonini M
    Drugs; 2001; 61(3):317-32. PubMed ID: 11293643
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Irritable bowel syndrome: new pharmaceutical approaches to treatment.
    Farthing MJ
    Baillieres Best Pract Res Clin Gastroenterol; 1999 Oct; 13(3):461-71. PubMed ID: 10580922
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Update in the therapeutic management of irritable bowel syndrome.
    Villanueva A; Domínguez-Muñoz JE; Mearin F
    Dig Dis; 2001; 19(3):244-50. PubMed ID: 11752844
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Management of irritable bowel syndrome: novel approaches to the pharmacology of gut motility.
    Scarpignato C; Pelosini I
    Can J Gastroenterol; 1999 Mar; 13 Suppl A():50A-65A. PubMed ID: 10202210
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Drug treatment options for irritable bowel syndrome: managing for success.
    Dunphy RC; Verne GN
    Drugs Aging; 2001; 18(3):201-11. PubMed ID: 11302287
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The brain-gut axis in irritable bowel syndrome--clinical aspects.
    Mach T
    Med Sci Monit; 2004 Jun; 10(6):RA125-31. PubMed ID: 15173682
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Drug therapy options for patients with irritable bowel syndrome.
    Talley NJ
    Am J Manag Care; 2001 Jul; 7(8 Suppl):S261-7. PubMed ID: 11474911
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rome III functional constipation and irritable bowel syndrome with constipation are similar disorders within a spectrum of sensitization, regulated by serotonin.
    Shekhar C; Monaghan PJ; Morris J; Issa B; Whorwell PJ; Keevil B; Houghton LA
    Gastroenterology; 2013 Oct; 145(4):749-57; quiz e13-4. PubMed ID: 23872499
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of the Diary for Irritable Bowel Syndrome Symptoms to Assess Treatment Benefit in Clinical Trials: Foundational Qualitative Research.
    Fehnel SE; Ervin CM; Carson RT; Rigoni G; Lackner JM; Coons SJ;
    Value Health; 2017 Apr; 20(4):618-626. PubMed ID: 28408004
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Functional diarrhea - pathophysiology, investigation and treatment].
    Schaub N; Degen L
    Ther Umsch; 2014 Sep; 71(9):551-8. PubMed ID: 25154691
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tegaserod for constipation-predominant irritable bowel syndrome.
    Kale-Pradhan PB; Wilhelm SM
    Pharmacotherapy; 2007 Feb; 27(2):267-77. PubMed ID: 17253916
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Defining and diagnosing irritable bowel syndrome.
    Schuster MM
    Am J Manag Care; 2001 Jul; 7(8 Suppl):S246-51. PubMed ID: 11474909
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Management of irritable bowel syndrome.
    Viera AJ; Hoag S; Shaughnessy J
    Am Fam Physician; 2002 Nov; 66(10):1867-74. PubMed ID: 12469960
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment goals in irritable bowel syndrome.
    Kellow JE
    Int J Clin Pract; 2001 Oct; 55(8):546-51. PubMed ID: 11695076
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Therapeutic approach to the patient with irritable bowel syndrome.
    Camilleri M
    Am J Med; 1999 Nov; 107(5A):27S-32S. PubMed ID: 10588170
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Role of serotonin in the pathophysiology of the irritable bowel syndrome].
    Moskwa A; Boznańska P
    Wiad Lek; 2007; 60(7-8):371-6. PubMed ID: 18175558
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tegaserod and other serotonergic agents: what is the evidence?
    Chey WD
    Rev Gastroenterol Disord; 2003; 3 Suppl 2():S35-40. PubMed ID: 12776001
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diagnostic approach to the patient with irritable bowel syndrome.
    Schmulson MW; Chang L
    Am J Med; 1999 Nov; 107(5A):20S-26S. PubMed ID: 10588169
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnostic and therapeutic strategies in the irritable bowel syndrome.
    Cremonini F; Talley NJ
    Minerva Med; 2004 Oct; 95(5):427-41. PubMed ID: 15467518
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 38.